Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers

NCT02794740 is registered in ClinicalTrials.gov with Tianjin XinChen-Techfields Pharma Co., LTD. as lead sponsor.

NCT NCT02794740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02794740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers
Lead sponsor
Tianjin XinChen-Techfields Pharma Co., LTD.
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2016
Completion date
March 29, 2017
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis